198 related articles for article (PubMed ID: 15699113)
1. Induction of obliterative airway disease in murine tracheal allografts by CD8+ CTLs recognizing a single minor histocompatibility antigen.
Higuchi T; Maruyama T; Jaramillo A; Mohanakumar T
J Immunol; 2005 Feb; 174(4):1871-8. PubMed ID: 15699113
[TBL] [Abstract][Full Text] [Related]
2. Chronic rejection of murine cardiac allografts discordant at the H13 minor histocompatibility antigen correlates with the generation of the H13-specific CD8+ cytotoxic T cells.
Yang J; Jaramillo A; Liu W; Olack B; Yoshimura Y; Joyce S; Kaleem Z; Mohanakumar T
Transplantation; 2003 Jul; 76(1):84-91. PubMed ID: 12865791
[TBL] [Abstract][Full Text] [Related]
3. Indirect minor histocompatibility antigen presentation by allograft recipient cells in the draining lymph node leads to the activation and clonal expansion of CD4+ T cells that cause obliterative airways disease.
Richards DM; Dalheimer SL; Ehst BD; Vanasek TL; Jenkins MK; Hertz MI; Mueller DL
J Immunol; 2004 Mar; 172(6):3469-79. PubMed ID: 15004147
[TBL] [Abstract][Full Text] [Related]
4. T-cell and major histocompatibility complex requirements for obliterative airway disease in heterotopically transplanted murine tracheas.
Kelly KE; Hertz MI; Mueller DL
Transplantation; 1998 Sep; 66(6):764-71. PubMed ID: 9771840
[TBL] [Abstract][Full Text] [Related]
5. Different kinetics of obliterative airway disease development in heterotopic murine tracheal allografts induced by CD4+ and CD8+ T cells.
Higuchi T; Jaramillo A; Kaleem Z; Patterson GA; Mohanakumar T
Transplantation; 2002 Sep; 74(5):646-51. PubMed ID: 12352880
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of obliterative airway disease development following heterotopic murine tracheal transplantation by costimulatory molecule blockade using anti-CD40 ligand alone or in combination with donor bone marrow.
Fernández FG; McKane B; Marshbank S; Patterson GA; Mohanakumar T
J Heart Lung Transplant; 2005 Jul; 24(7 Suppl):S232-8. PubMed ID: 15993779
[TBL] [Abstract][Full Text] [Related]
7. Trachea allograft class I molecules directly activate and retain CD8+ T cells that cause obliterative airways disease.
Richards DM; Dalheimer SL; Hertz MI; Mueller DL
J Immunol; 2003 Dec; 171(12):6919-28. PubMed ID: 14662899
[TBL] [Abstract][Full Text] [Related]
8. Indirect recognition and antibody production against a single mismatched HLA-A2-transgenic molecule precede the development of obliterative airway disease in murine heterotopic tracheal allografts.
Smith MA; Jaramillo A; SivaSai KS; Naziruddin B; Kaleem Z; Patterson GA; Mohanakumar T
Transplantation; 2002 Jan; 73(2):186-93. PubMed ID: 11821728
[TBL] [Abstract][Full Text] [Related]
9. Role of airway epithelial injury in murine orthotopic tracheal allograft rejection.
Kuo E; Bharat A; Shih J; Street T; Norris J; Liu W; Parks W; Walter M; Patterson GA; Mohanakumar T
Ann Thorac Surg; 2006 Oct; 82(4):1226-33. PubMed ID: 16996912
[TBL] [Abstract][Full Text] [Related]
10. Pirfenidone inhibits obliterative airway disease in a murine heterotopic tracheal transplant model.
McKane BW; Fernandez F; Narayanan K; Marshbank S; Margolin SB; Jendrisak M; Mohanakumar T
Transplantation; 2004 Mar; 77(5):664-9. PubMed ID: 15021826
[TBL] [Abstract][Full Text] [Related]
11. DNA fusion vaccines induce targeted epitope-specific CTLs against minor histocompatibility antigens from a normal or tolerized repertoire.
Rice J; Buchan S; Dewchand H; Simpson E; Stevenson FK
J Immunol; 2004 Oct; 173(7):4492-9. PubMed ID: 15383580
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of obliterative airway disease development in murine tracheal allografts by matrix metalloproteinase-9 deficiency.
Fernández FG; Campbell LG; Liu W; Shipley JM; Itohara S; Patterson GA; Senior RM; Mohanakumar T; Jaramillo A
Am J Transplant; 2005 Apr; 5(4 Pt 1):671-83. PubMed ID: 15760390
[TBL] [Abstract][Full Text] [Related]
13. Orthotopic and heterotopic tracheal transplantation model in studying obliterative bronchiolitis.
Fan K; Qiao XW; Nie J; Yuan L; Guo HZ; Zheng ZK; Li JS; Wang JJ; Jiang K
Transpl Immunol; 2013 Jun; 28(4):170-5. PubMed ID: 23619376
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of obliterative airway disease in rat tracheal allografts infected with recombinant rat cytomegalovirus.
Reichenspurner H; Soni V; Nitschke M; Berry GJ; Brazelton T; Shorthouse R; Huang X; Boname J; Girgis R; Raitz BA; Mocarski E; Sandford G; Morris RE
J Heart Lung Transplant; 1998 May; 17(5):439-51. PubMed ID: 9628562
[TBL] [Abstract][Full Text] [Related]
15. Pluripotent allospecific CD8+ effector T cells traffic to lung in murine obliterative airway disease.
West EE; Lavoie TL; Orens JB; Chen ES; Ye SQ; Finkelman FD; Garcia JG; McDyer JF
Am J Respir Cell Mol Biol; 2006 Jan; 34(1):108-18. PubMed ID: 16195540
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of the immune response to mouse non-MHC transplantation antigens in vivo: the H60 histocompatibility antigen dominates over all others.
Choi EY; Yoshimura Y; Christianson GJ; Sproule TJ; Malarkannan S; Shastri N; Joyce S; Roopenian DC
J Immunol; 2001 Apr; 166(7):4370-9. PubMed ID: 11254691
[TBL] [Abstract][Full Text] [Related]
17. Donor antigen-presenting cells are important in the development of obliterative airway disease.
Szeto WY; Krasinskas AM; Kreisel D; Popma SH; Rosengard BR
J Thorac Cardiovasc Surg; 2000 Dec; 120(6):1070-7. PubMed ID: 11088028
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive assessment of determinant specificity, frequency, and cytokine signature of the primed CD8 cell repertoire induced by a minor transplantation antigen.
Heeger PS; Valujskikh A; Lehmann PV
J Immunol; 2000 Aug; 165(3):1278-84. PubMed ID: 10903727
[TBL] [Abstract][Full Text] [Related]
19. Prevention of obliterative airway disease in HLA-A2-transgenic tracheal allografts by neutralization of tumor necrosis factor.
Smith CR; Jaramillo A; Lu KC; Higuchi T; Kaleem Z; Mohanakumar T
Transplantation; 2001 Nov; 72(9):1512-8. PubMed ID: 11707738
[TBL] [Abstract][Full Text] [Related]
20. Reepithelialized orthotopic tracheal allografts expand memory cytotoxic T lymphocytes but show no evidence of chronic rejection.
Cleven HA; Genden EM; Moran TM
Transplantation; 2005 Apr; 79(8):861-8. PubMed ID: 15849536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
